NDC properties for NDC 9 10223-0202
NDC item 10223020201
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-1 |
| NDC Item | 10223020201 |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
NDC item 10223020202
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-2 |
| NDC Item | 10223020202 |
| packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-2) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
NDC item 10223020204
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-4 |
| NDC Item | 10223020204 |
| packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-4) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
NDC item 10223020205
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-5 |
| NDC Item | 10223020205 |
| packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-5) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
NDC item 10223020206
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-6 |
| NDC Item | 10223020206 |
| packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-6) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
NDC item 10223020207
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-7 |
| NDC Item | 10223020207 |
| packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-7) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
NDC item 10223020208
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-8 |
| NDC Item | 10223020208 |
| packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-8) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
NDC item 10223022501
| NDC 9 | 10223-0225 |
|---|---|
| NDC 10 | 10223-0225-1 |
| NDC Item | 10223022501 |
| packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0225-1) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
NDC item 10223022601
| NDC 9 | 10223-0226 |
|---|---|
| NDC 10 | 10223-0226-1 |
| NDC Item | 10223022601 |
| packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0226-1) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |